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Abstract: Consolidation of contextual memories after a stressful encounter is essential for the survival
of an organism and in allowing a more appropriate response to be elicited should the perceived
threat reoccur. Recent evidence has explored the complex role that epigenetic mechanisms play in the
formation of such memories, and the underlying signaling pathways are becoming more apparent.
The glucocorticoid receptor (GR) has been shown to play a key role in these events having both
genomic and non-genomic actions in the brain. GR has been shown to interact with the extracellular
signal-regulated kinase mitogen-activated protein kinase (ERK MAPK) signaling pathway which,
in concert, drives epigenetic modifications and chromatin remodeling, resulting in gene induction and
memory consolidation. Evidence indicates that stressful events can have an effect on the offspring
in utero, and that epigenetic marks altered early in life may persist into adulthood. A new and
controversial area of research, however, suggests that epigenetic modifications could be inherited
through the germline, a concept known as transgenerational epigenetics. This review explores the
role that epigenetic processes play in the central nervous system, specifically in the consolidation of
stress-induced memories, the concept of transgenerational epigenetic inheritance, and the potential
role of epigenetics in revolutionizing the treatment of stress-related disorders through the emerging
field of pharmacoepigenetics and personalized medical treatment.
Keywords: epigenetics; cognition; glucocorticoid hormone; stress; memory; learning; hippocampus;
glucocorticoid receptor; mineralocorticoid receptor; immediate-early gene
1. Introduction
The stress response is initiated when an animal encounters a perceived harmful event or situation,
physical and/or psychological, that threatens to disrupt homeostasis and requires appropriate
physiological and behavioral responses in order to cope with the stressor [1,2]. A physical challenge
involves the minor cognitive interpretation of the event and results in an immediate physiological
response. In contrast, a psychological stressor requires the animal to assess the situation and make a
decision through cognitive evaluations. These stressors evoke neurobiological changes, which result in
behavioral adaption to increase the animal’s chance of survival [3,4]. Furthermore, memory formation
of stressful events is required so that an individual will respond more fittingly should the stressful
situation be encountered again. It should be noted that most stressful situations, if not all, are mixed in
their physical versus psychological nature.
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The body responds to stressors through mobilization of different physiological pathways
including fast activation of the sympathetic nervous system, including the sympathoadrenomedullary
system (SAS), and the slower hypothalamic-pituitary-adrenal (HPA) axis. SAS activation results in
immediate release of adrenaline from the adrenal medulla into the systemic circulation to prepare
the animal for the ‘fight or flight’ response. Activation of the HPA axis results in the secretion of
glucocorticoid hormones (GCs; predominantly corticosterone in rodents such as rats and mice, cortisol
in humans) from the adrenal cortex into the circulation.
GCs bind to corticosteroid receptors, i.e., the mineralocorticoid receptors (MRs (encoded by
the Nr3c2 gene) and GC receptors (GRs; Nr3c1)), that co-localize in parts of the limbic system, i.e.,
the hippocampus [5–7]. The molecular role that GCs play in producing long-lasting behavioral changes
appears to be highly complex involving both genomic and non-genomic mechanisms. Classically,
as part of their genomic action, MRs and GRs act as ligand-dependent transcription factors that control
the expression of GC target genes through interaction with GC-response elements (GREs) located
throughout the genome often within or in the vicinity of these genes [8–10]. Non-genomic effects
have been demonstrated regarding membrane-bound MRs and GRs, resulting in neurophysiological
changes [11] and, through the interactions of GRs with intracellular signaling pathways such as the
extracellular signal-regulated kinase mitogen-activated protein kinase (ERK MAPK) pathway in the
hippocampus, resulting in epigenetic and genomic changes, and behavioral adaptation [12,13].
The term epigenetics was first coined by Waddington in 1942 to describe phenotype
development [14]. We now know that although cells all contain the same genetic information they
display a rich variety of phenotypes, varying greatly in morphology and function. This is now
recognized as the origin of the differential expression of genes that occurs without changes to the DNA
sequence. Furthermore, epigenetics has been regarded as the ‘molecular bridge’ between the cell’s
genotype and the potentially ever-changing phenotype.
This review will explore the role of epigenetic and molecular mechanisms in the central nervous
system (CNS) covering current mechanisms underpinning stress-related learning and memory,
transgenerational epigenetics, the role epigenetics plays in neuropsychiatric disorders, and the potential
of using epigenetic modifications as biomarkers, or to inform the most effective course of treatment.
2. Epigenetics
Epigenetic mechanisms determine the way genes are organized in the cell nucleus and influence
their expression by changing the conformation of the chromatin and therefore the accessibility
of the DNA for transcription factors, other factors, and the transcriptional machinery. These
epigenetic mechanisms include post-translational histone modifications (PTMs), DNA methylation,
and non-coding RNAs, resulting in activation, silencing, or poising of genes and thereby regulating
patterns of gene expression. Epigenetic mechanisms are highly dynamic and allow cells to respond to
changes in their environment, thereby contributing to the plasticity of the brain and thus the way the
brain responds to environmental challenges such as stress and, as a consequence, facilitating learning
and memory [15]. Learning and the formation of memories require gene transcription and protein
synthesis in vivo [16], which, amongst others, contribute to the structural and functional remodeling of
synapses between neurons [17]. Recent evidence suggests that these epigenetic modifications may also
be carried across generations, which has instigated a new area of research termed transgenerational
epigenetic inheritance.
2.1. Epigenetic Mechanisms in Stress-Related Learning and Memory Paradigms
Epigenetic mechanisms play a key role in how animals consolidate memories associated with a
stressful event. It should be noted that any behavioral test imposed on rodents will represent a stressful
situation for such animals. Therefore, stress is an integral part of behaviorally relevant challenges to
these rodents. Examples of such behavioral challenges are contextual fear conditioning, Morris water
maze (MWM) learning, and the forced swim (FS) test [4,12,13,18]. The different types of PTMs can
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be addressed individually in stress-related learning and memory paradigms (as below); however, it
should be considered that many PTMs work together in order to direct gene transcription and that this
can be in a tissue/cell-specific manner.
2.1.1. Acetylation
Acetylation of specific histones and/or specific residues has been found to be associated with
long-term memory formation. For example, after contextual fear conditioning, histone H3 but not H4
acetylation increased specifically within the CA1 region of the hippocampus, which was dependent of
the activation of N-methyl-D-aspartate (NMDA) receptors (NMDA-Rs) and, subsequently, the ERK
MAPK signaling pathway [19]. Long-term memory was enhanced upon the use of the HDAC inhibitor
NaBut (sodium butyrate) in vivo prior to contextual fear conditioning [19]. In MWM studies, increased
acetylation of histone H4 at lysine 12 (H4K12ac) and pan acetylation of H2B in the hippocampus
were found to be specifically associated with spatial learning [20]. This observation demonstrates that
distinct histones are subject to selective modifications due to a behavioral challenge. Furthermore,
recent studies have shown that epigenetic modifications can vary not only between different regions
of the brain but also between the sub-regions. For example, Castellano and colleagues [21] discovered
that after training in a one-day redundant place/cue version of the MWM there was an increase in
pan-acetylated H3 and H4 and a decrease in the acetylation of H3 lysine 9 (H3K9) within the CA1
sub-region. In parallel, in the CA3 region only H3 pan-acetylation was increased, whereas in the
dentate gyrus (DG) pan-acetylation of H3 and phosphorylation of H3 at serine 10 (H3S10p) occurred
in a small subset of DG granular neurons [22]. These experiments further demonstrate the complexity
of the epigenetic histone modifications.
2.1.2. Phosphorylation
In the FS test the behavioral immobility response observed 24 h or even several weeks after the
initial test is an adaptive behavioral response that depends on a GR-mediated action of GC hormones
in the DG of the hippocampus [4,13,23–25]. We found, serendipitously, that forced swimming raises
histone H3 phosphorylation (H3S10p) selectively in sparsely distributed, mature dentate granule
neurons in rats and mice [26,27]. It appeared that this histone mark exists in combination with an
acetylation mark at lysine14 (i.e., H3S10p-K14ac; and lysine9 H3K9ac-S10p; [12]), indicating that this
combinatorial epigenetic mark could be involved in transcriptional activation [27,28]. Subsequent
studies showed that the formation of H3S10p-K14ac in DG neurons was dependent on signaling
through GRs and NMDA-Rs [13,27,28]. Furthermore, we established that a crucial link between forced
swimming-induced NMDA-R activation and the formation of H3S10p-K14ac in DG neurons is the
phosphorylation of ERK1/2 (by MAPK/ERK kinase (MEK)) and the recruitment of the nuclear kinases
MSK1/2 (mitogen- and stress-activated kinases 1 & 2) and ELK1 (ETS transcription factor 1) [13].
Previously, it has been demonstrated in vitro that the kinases ERK1/2 activate MSK1 [29] and
ELK1 [30,31] through phosphorylation. Studies in vitro have also shown that the ERK MAPK pathway
can activate Elk-1 through phosphorylation and activation of cAMP response element binding protein
(CREB) [31,32]. MSK1/2 is a H3S10 kinase, whereas Elk-1 can recruit the histone acetyl-transferase p300,
which can acetylate histone H3 at various lysine residues. Importantly, it was found that activation
of the NMDA-R/ERK1/2/MSK1/2-ELK1 signaling pathway was critical for the consolidation of the
behavioral immobility response [13,27,33]. Inspired by the pioneering work of Clayton et al. [34],
the role of the immediate early genes (IEGs) Fos and Egr1 in the FS paradigm was investigated.
These IEGs are involved in long-term memory paradigms like the MWM [35]. Based on a series of
pharmacological, gene deletion, immunohistochemical, and chromatin immunoprecipitation (ChIP)
studies, it was indeed found that the formation of H3S10p-K14ac is associated with the induction of
FOS and EGR1 in DG neurons [12,13,27,28]. Moreover, the induction of these IEGs in DG neurons was
also found to be dependent of signaling through GRs [13].
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The dependency of IEG induction and the behavioral immobility response of both GRs and
NMDA-R/ERK1/2/MSK1/2-Elk-1 signaling prompted the question about the biochemical basis of
this confluence of molecular pathways [13,36]. Based on co-immunoprecipitation and other studies
we found that GRs facilitate the phosphorylation (i.e., activation) of MSK1/2 and ELK1 through
a fast protein-protein interaction with pERK1/2 [13]. These observations explained how the GR
antagonist impaired the phosphorylation of MSK1/2 and ELK1, resulting downstream in a decline in
both H3S10p-K14ac formation and IEG induction, without affecting ERK1/2 phosphorylation [13].
For an overview of these interacting signaling and epigenetic pathways, see Figure 1. The interaction
of GRs with ERK1/2/MSK1/2-ELK1 signaling presents a novel non-genomic mechanism, which is
quite distinct from its classical genomic mode of action (Figure 1).
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Egr1, thereby facilitating the induction of gene transcription. Immediate-early gene induction is of 
critical importance for the consolidation of (contextual) memories associated with the stressful event. 
The recruitment of DNA methyltransferase 3A (DNMT3A) in conjunction with the concentration of 
the endogenous methyl donor SAM plays an important role in the DNA methylation state of the 5′-
UTRs and promoter regions of the immediate-early genes Fos and Egr1, thereby controlling their 
expression as well as the consolidation of memories. See text for further details and literature 
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training. 
After the discovery of the role of the NMDA-R/ERK/MAPK signaling pathway in evoking 
epigenetic (H3S10p-K14ac) changes and induction of IEGs in the FS and novelty tests, it was 
hypothesized that a similar sequence of events may be taking place in the MWM. It is also well-
known that MWM learning is highly dependent on NMDA-R and ERK MAPK signaling [37,38]. 
Figure 1. Psychological stress-evoked signaling and epigenomic responses in sparse dentate gyrus
neurons underpinning gene transcription and contextual memory consolidation. The stressful
challenge associated with forced swimming, Morris water maze learning, contextual fear conditioning,
and novelty results in the activation of NMDA-R-ERK-MAPK pathways and GRs which, in conjunction,
results in the activation of nuclear MSK1 and ELK1/p300. The activation of this histone kinase and
histone acetyl-transferase leads to the formation of the combinatorial H3K9ac-S10p–K14ac histone
marks within the promoter regions of the immediate-early genes Fos and Egr1, thereby facilitating
the indu tion of ge e transcription. Immediate- arly gene induction is of critical importanc for the
consolidation of (contextual) memorie associated with the stressful event. The recruitment of DNA
methyltransferase 3A (DNMT3A) in conjunction with the concentration of the endogenous methyl
donor SAM plays an important role in the DNA methylation state of the 5′-UTRs and promoter
regions of the immediate-early genes Fos and Egr1, thereby controlling their expression as well as the
consolidation of memories. See text for further details and literature references. FS: forced swimming;
FC: contextual fear conditioning; MWM: Morris water maze training.
After the discovery of the role of the NMDA-R/ERK/MAPK signali g pathway in evoking
epigenetic (H3S10p-K14ac) changes and induction of IEGs in the FS and novelty tests, it was
hypothesized that a similar sequence of events may be taking place in the MWM. It is also well-known
that MWM learning is highly dependent on NMDA-R and ERK MAPK signaling [37,38]. Furthermore,
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deletion of MSK1 had been shown to result in impaired MWM learning and contextual fear learning, as
well as a decrease in histone acetylation and phosphorylation after learning [39]. We found a positive
correlation between the average latency to find the platform and the number of H3S10p-K14ac-positive
DG neurons. Moreover, we found a significant increase of H3K9ac-S10p formation at the promoters of
the Fos and Egr1 genes but not at the Arc gene promoters in rats that had undergone MWM training,
compared with baseline controls [22].
2.1.3. Histone and DNA Methylation
Contextual fear conditioning experiments have been instrumental in elucidating the potential role
that the complex PTMs at histones involving methylation may play in learning and memory. Tri- and
di-methylation of H3K4 (H3K4me3 and H3K4me2, respectively) were increased after contextual fear
conditioning in the CA1 sub-region of the hippocampus [40]. Specifically, H3K4me3 increased at
the transcriptionally active Egr1 and brain-derived neurotrophic factor (Bdnf ) genes after contextual
fear conditioning. Interestingly, however, DNA methylation also increased at the promoter of the
Egr1 gene but decreased at the Bdnf promoter of transcript 1 [40]. These findings are intriguing
since DNA methylation is thought of as a transcriptional repressor and therefore was expected to
reduce gene transcription [40]. It was suggested that MeCP2 could be binding to the methylated DNA
along with CREB1, which can actively regulate gene transcription as demonstrated by Chahrour and
colleagues [41].
Generally, it is thought that DNA methylation is associated with condensed and compacted
chromatin, shielding binding sites from their transcription factors, and resulting in gene repression.
DNA demethylation is thought to have the opposite effect, allowing transcriptional activation, which is
essential for synaptic plasticity and learning and memory. This straightforward concept was supported
by early studies demonstrating that depolarization of neurons in vitro results in a reduction of DNA
methylation of the Bdnf gene and an increase in gene transcription [42]. Three functional enzymes
responsible for DNA methylation in mammals have been identified, namely DNA methyltransferase 1
(DNMT1), DNA methyltransferase 3A (DNMT3A), and DNA methyltransferase 3B (DNMT3B) [43].
Based on the notion that DNA methylation results in gene silencing, it was assumed that DNMT
inhibitors would lead to enhanced synaptic plasticity and potentially enhance learning and memory.
Interestingly, pretreatment with DNMT inhibitors Zebularine and 5-aza-2′-deoxycytidine (5-Aza)
resulted in blockade of synaptic plasticity [44]. These experiments showed that long-term potentiation
may be affected by both activation and inhibition of gene transcription. These surprising findings may,
at least in part, be related to the recently reported observations that certain DNMTs can act as DNA
methyltransferases as well as DNA demethylases, depending on the cell activation status and methyl
donor concentration [45–47].
DNA methylation changes and DNMT expression have been investigated in various animal
models. Chronic social defeat stress was shown to induce prolonged anxiety-like behavior and to
result in a reduction of DNMT3A mRNA levels and global DNA methylation levels in the medial
prefrontal cortex (mPFC). DNMT3A knock-down in the mPFC resulted in enhanced anxiety-like
behavior similar to mice that had undergone chronic social defeat stress, while over-expression
resulted in a reduction of anxiety levels [48]. It is well-known that there is a higher prevalence of
depression and anxiety disorders in females than in males and the symptoms displayed are different
as well [49,50]. Hodes et al. studied the neurobiological basis of these sex differences in an animal
model using sub-chronic variable stress. Using this model, they demonstrated sex differences in the
transcriptomic profile in the Nucleus Accumbens, which appeared to be associated with susceptibility
versus resilience to sub-chronic variable stress. Data indicated that DNMT3A may play an important
role in the mRNA expression changes observed in this brain reward region [51].
Furthermore, recent research has uncovered the true complexity of the range of modifications
occurring at these ‘methylation’ sites on DNA [52] (Figure 2). Various intermediate modifications may
have their own specific regulatory control modalities on gene transcription. One of these intermediate
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marks, 5-formylcytosine (5fC), derived from ten-eleven translocation gene protein 1 (TET1)-mediated
oxidation of 5-hydroxymethylation (5-hmC), has been shown to be associated with the recruitment of
the transcription factor ING1 (inhibitor of growth family member 1). This association has been linked
to the transcription of essential genes within the mPFC that are required for successful fear extinction
training in mice [53].
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Figure 2. Epigenetic modifications of DNA. Cytosines within the DNA sequence can be dynamically
modified into stable forms which may have specific functional roles. Abbreviations: DNA
methyltransferases (DNMTs), ten-eleven translocation (TET) enzymes, activation-induced cytidine
deaminase (AID), apolipoprotein B mRNA-editing enzyme catalytic polypeptides (APOBEC), thymine
DNA glycosylase (TDG), base excision repair (BER) pathway.
Lubin and colleagues showed that contextual fear conditioning induced differential regulation
of exon-specific Bdnf mRNA transcripts in the hippocampus, which were associated with changes in
the Bdnf DNA methylation pattern [54]. BDNF is known to contribute to neuronal activity-dependent
processes such as long-term potentiation [55]. Furthermore, DNA methylation appears to determine
the Bdnf transcripts produced during fear memory consolidation [54]. Inhibition of DNMT action using
the DNA methylation inhibitor Zebularine in rats resulted in Bdnf demethylation. This demethylation
caused an associated increase in the output of Bdnf gene transcripts and, surprisingly, blocked memory
consolidation [54]. Contrary to expectations, inhibiting DNMTs prevented DNA demethylation
within specific sites of the Bdnf gene in rats [54]. As mentioned before, such effects can potentially
be explained by DNA de-methylase activity of certain DNMTs; however, at the time of the above
study [54], it was considered possible that the observed repression was mediated through a memory
suppressor gene such as the protein phosphatase 1 (PP1) [56]. It has also been suggested that DNMTs
can regulate both DNA methylation and demethylation via indirect mechanisms and/or pathways [57].
Fear conditioning is associated with an increase in the methylation specifically at the promoter of
PP1 and a decrease in DNA methylation at the promoter of the plasticity-associated gene Reelin [56].
These results show that DNA methylation and demethylation is clearly very dynamic, and both are
essential for neuronal plasticity and memory consolidation. A recent study has shown for the first time
that DNMT3B1 can be recruited to regions of active transcription, specifically in regions with elevated
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H3K36me3, which appeared to guide binding of DNMT3B1 and resulted in site-specific de novo
methylation in mouse stem cells [58]. This study demonstrates that DNMT3B1 is binding to actively
transcribed genes in a cell-type specific manner, resulting in de novo methylation and reduction of
gene transcription. These experiments indicate that complex mechanisms control DNA methylation
status, conferring the precise and dynamic nature of DNA methylation/demethylation processes.
Miller and Sweatt also demonstrated that contextual fear conditioning results in an increase in de novo
Dnmt3a and Dnmt3b gene expression in the hippocampus and that inhibition of the DNMTs blocked
memory formation. Future work delineating the DNA methyl-transferase versus DNA demethylase
activity status of DNMTs under various conditions of behavioral/neuronal activity will clarify the
exact role of these enzymes and DNA methylation status in learning and memory paradigms [56].
In terms of epigenetic mechanisms, in addition to histone modifications, we investigated changes
in the DNA methylation status of the IEGs Fos and Egr1 in the FS paradigm. Forced swimming resulted
in a decrease in DNA methylation at certain 5′-cytosine-phosphate-guanine-3′ (CpGs) within the c-Fos
and Egr-1 gene promoters and 5′-untranslated regions specifically in DG neurons; there was no effect
in the CA regions of the hippocampus [12]. Furthermore, administration of the endogenous methyl
donor S-adenosyl methionine (SAM) before the FS challenge reversed the effect of the stressor on the
DNA methylation level of the IEGs. Hence, pre-treatment with SAM before forced swimming resulted
in an increased DNA methylation of the gene promoters/5′-UTR of Fos and Egr1 and decreased
expression of these IEGs specifically within the DG. SAM administration also interfered with the
memory consolidation process post-forced swimming, because the rats presented significantly less
behavioral immobility than the vehicle-treated animals during the FS re-test 24 h later [12]. Importantly,
SAM exerted no effects on the forced swimming-induced formation of H3S10p-K14ac in DG neurons;
thus, the methyl donor did not affect the FS-activated signaling pathway required for IEG induction in
these neurons [12]. Follow-up experiments revealed that the stressful challenge resulted in increased
mRNA expression of Dnmt3a, but not Dnmt3b or Tet1 (an enzyme that catalyzes the conversion of
5-mC to 5-hmC, a proposed first step in active DNA demethylation), specifically in the DG. Moreover,
our ChIP studies showed an increased binding of DNMT3A to gene promoters of Fos and Egr1 [12].
An increased binding of DNMT3A appears counter-intuitive in the face of decreased DNA methylation
after FS. Under conditions of elevated intracellular Ca2+ levels, however, it has been shown in vitro
that DNMT3A acts as a DNA demethylase [45–47]. As events resulting in IEG induction in the DG
neurons are NMDA-R-dependent, elevated Ca2+ levels are to be expected in these neurons, potentially
favoring DNMT3A to act as a DNA demethylase. Under conditions of elevated SAM levels, despite
risen Ca2+ levels, the enzymatic activity of DNMT3A may revert to that of a DNA methyltransferase
activity [45–47], explaining the enhanced DNA methylation of the Fos and Egr1 gene promoter/5′-UTR
region after FS in the presence of elevated SAM [12]. Thus, the DNA methylation status of these IEGs
is governed by environmental stimuli (e.g., stress), the availability of the methyl donor SAM, and
other physiological factors (e.g., Ca2+). Our studies have shown that the forced swimming-induced
behavioral immobility response is controlled by GRs, NMDA-Rs, the ERK1/2/MSK1/2-ELK1 signaling
pathway, formation of H3K9ac-S10p-K14ac, and DNA methylation status at IEGs in DG neurons,
whereby the forced swimming-evoked DNA demethylation plays a critical go-no go role for gene
transcription and memory consolidation (Figure 1).
GRs clearly act on neuronal functions via different mechanisms but are themselves subjects
of control as well. For instance, and relevant for FS-associated processes, we discovered that GR
expression is altered after a FS event as a result of DNA methylation changes and microRNA expression.
Within 15 min of this stressful challenge, we found a significant reduction in GR mRNA expression,
but not MR mRNA expression, specifically in the DG [59]. We found that forced swimming results
in increased DNA methylation of the Nr3c1 gene associated with an enhanced binding of DNMT3A,
which may explain the reduction in gene expression after stress. Furthermore, as it has previously been
shown that the microRNA mir-124a can reduce GR mRNA expression in vitro [60], we investigated the
expression of this microRNA under baseline conditions and after FS stress in vivo. Forced swimming
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indeed evoked a significantly increased expression of mir124a in the DG, which was negatively
correlated with the expression of GR mRNA expression. Using ChIP we investigated binding of GRs
to a putative negative GRE within the Nr3c1 (GR) gene after FS to determine if GR was capable of
suppressing its own expression, but no significant binding in this region was found [59]. These novel
observations add to the complexity of regulatory mechanisms controlling GR expression and function
in the brain.
3. Glucocorticoid Hormone Action at the Genomic Level after Stress
During and after stressful events, GC hormones play an important role in the brain in regulating
adaptive physiological and behavioral responses relevant to the stressful challenge [18]. GCs are
secreted from the adrenal glands following HPA axis activation. In higher limbic brain structures like
the hippocampus and amygdala, and in the prefrontal cortex, GCs play a critical role in the cognitive
processing of (psychologically) stressful challenges [3,4,61]. In addition, GCs elicit negative feedback
to hypothalamic nuclei (most importantly, the paraventricular nucleus (PVN)) and other parts of the
brain to dampen the surge in HPA axis activity after acute stressful events [4,5,61].
The principal brain structure involved in the consolidation of contextual memories associated
with such challenges is the hippocampus. It has been known for several decades that, in rodents
and humans, GCs are vital for memory consolidation after stressful encounters [4]. It is, however,
still unclear exactly how GCs act on the hippocampus to fulfill this function. One notion is becoming
increasingly clear though: disruption of GC action is detrimental for brain function as it increases
vulnerability for developing mental disorders like major depression, anxiety, and schizophrenia, and
possibly neurodegenerative diseases as well.
In view of the scope of this article and the vast GC-action-in-the-brain field, we cannot provide an
elaborate account about all aspects here. There have been two significant developments that we wish
to address. Our novel finding on the non-genomic interaction of GRs with the NMDA-R/ERK MAPK
pathway with epigenetic and gene transcriptional consequences and behavioral implications has been
described earlier in this review. The other new data concern the interaction of MRs and GRs with the
hippocampal genome after stress in vivo.
As mentioned before, GCs bind to MRs and GRs in the brain, which act as ligand-dependent
transcription factors affecting the transcription of GC target genes via interaction with GC response
elements (GREs) [62,63]. These corticosteroid receptors can affect transcription in different ways such
as directly recruiting chromatin modifying complexes [64]; however, they can also interact with other
transcription factors [65] in order to initiate transcription. GRs are ubiquitously localized in the brain,
whereas MRs are primarily located in the hippocampus [5,6,66,67]. Hippocampal MRs and GRs are
co-localized in pyramidal and granular neurons [7]. GC secretion from the adrenal glands shows
two distinct patterns of activity [68]. First, as a result of the pulsatile secretion pattern with varying
amplitudes across the day, the baseline levels of GCs follow a circadian rhythm in rodents with low
levels in early morning (AM) hours and substantially higher levels in the late afternoon/early evening
(PM) at the start of the active phase [69–71]. Second, as a result of exposure to stress, there is a surge in
GC secretion, which can be generated at any time of the day, the amplitude of which usually surpasses
the circadian-induced rises in the GC secretion [5,66,69].
The occupancy pattern of MRs and GRs under varying circulating GC conditions was published
by Reul and de Kloet more than 30 years ago [5]. The occupancy of hippocampal GRs by endogenous
GCs (in the rat) strongly depends on the circulating hormone concentration with very low occupancy
levels during the early morning and much higher occupancy levels during the evening and after
stress [5,66]. In contrast, MRs, due to their very high affinity for binding corticosterone (>10-fold higher
binding affinity than that displayed by GRs), were found to be highly occupied by hormones under all
physiological (baseline or stress) conditions [5,66]. Based on these early observations, the concept was
developed that apparently MRs exert a tonic action of brain function, whereas GRs are involved in
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neuroendocrine and brain functions associated with elevated GC levels such as negative feedback on
HPA axis activity and memory consolidation [3,5,61,72].
Until recently, it was unknown how hippocampal MRs and GRs interact with the genome under
baseline and stress conditions in vivo. Previously, pharmacological approaches had been used to study
the genomic interaction of these receptors by injecting GCs into adrenalectomized (ADX) rats [73,74].
Using ChIP, we used intact rats to investigate the binding of MRs and GRs to GREs within promoters
or intronic regions of the GC target genes Fkbp5 (FK506-binding protein 5), Per1 (period 1) and Sgk1
(serum/glucocorticoid regulated kinase 1) in an extensive time course analysis after FS stress [10].
Binding of both MRs and GRs to these GREs was low in hippocampal chromatin from rats killed
under early morning baseline conditions but showed a significant, transient increase after forced
swimming with peak levels at 30 min post-stress [10]. Regarding GR, this GRE binding pattern was
expected as it dovetailed with the receptor’s occupancy/activation pattern post-stress [66]. In contrast,
the observed increase in MR to GRE binding after stress in these target genes was very surprising as we
had expected, based on its constant high hormone occupancy levels, that GRE-binding would be high
or near-maximal already under early morning baseline conditions; this was clearly not the case [10].
Thus, although MRs are occupied and located in the nucleus [67] under FS conditions, binding of the
MR to these GREs was much lower than expected; only after stress a substantial rise in binding was
observed. Elevated MR and GR binding levels were also observed under baseline conditions in the
evening when GC levels have risen due to the circadian drive [10].
The reason for this remarkable discovery could be that MR binding to GRE is relatively weak,
possibly requiring GRs for effective binding to GREs. This idea is supported by transfection studies
in vitro [75], which showed that transfection of just MR in monkey kidney COS-1 (CV-1 in Origin with
SV40 genes) cells resulted in weak (compared with GR only) DNA-binding and gene transcriptional
responses, but if MR and GR were co-transfected then binding and transcription were significantly
enhanced beyond levels of the individual receptors. Based on these observations, Trapp et al. [75]
proposed the concept that MRs and GRs, in addition to forming homodimers, may also form
heterodimers (Figure 3) under conditions of cellular co-localization. Subsequently, heterodimer
formation has indeed been determined in cell culture and cell-free systems in vitro [75]; additional
references in [10]. Under conditions in vivo, however, heterodimerization of MR and GR had never
been shown. We embarked on a series of serial and tandem ChIP studies to investigate MR and GR
homo- and heterodimer formation at GREs of GC target genes in the hippocampus under baseline and
stress conditions. We discovered that after FS stress, MR and GR form heterodimers (as measured by
co-binding) at GREs within the Fkbp5 and Per1 genes, but not at the Sgk1 GRE [10]. In addition, evidence
was found for substantial GR homodimer formation after stress, but MR homodimer formation at
GREs remained relatively low. These findings support the notion that MR binding per se is rather weak,
requiring GR co-binding to strengthen its binding to GREs, but more research is required to strengthen
this concept. Alternative mechanisms may be playing a role in restraining access of MRs to GREs under
baseline early morning conditions, such as an action of negative steroid receptor co-regulators [10].
These MR and GR ChIP studies using hippocampus tissue have opened a new chapter in the
study of the genomic action of GCs in the brain. In addition to the heterodimer discovery, several other
key findings were made which have led to adjustments to how we view MR and GR action at the
hippocampal genome. We observed that, most clearly after stress, the level of MR and GR binding at
the chosen GREs within the classic GC-responsive genes Fkbp5, Per1 and Sgk1 were markedly different.
Overall, levels of binding (i.e., determined as enrichment after ChIP and quantitative polymerase
chain reaction (qPCR) analysis) were substantially higher at the Fkbp5 and Per1 GREs than at the Sgk1
GRE [10]. Regarding the Fkbp5 gene, the GRE referred to here is located within intron 5 of the rat Fkbp5
gene. There is another GRE within intron 5, upstream of the mentioned GRE, which has been shown
in vitro to be inactive and not bind any GRs [76]; indeed, in our study this GRE was relatively inactive
in response to FS stress [10]. Thus, it appears that the binding of MRs and GRs to GREs within genes
or at gene promoters and enhancer regions is very gene- and GRE-dependent, suggesting that access
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to GREs is tightly controlled. Further insight into the binding of GREs by MRs and GRs under baseline
and stress conditions across the entire rat genome is expected from ChIP studies in combination with
next-generation sequencing.
Comparison of different stressors (FS, novelty, and restraint stress), which produce distinct plasma
corticosterone responses, revealed that the level of MR and GR binding to GREs within Fkbp5, Per1 and
Sgk1 was not a function of the circulating hormone levels [10]. It appeared that the MR and GR binding
levels were similar across stressors and, thus, appeared to require a certain threshold concentration of
GCs to produce such receptor GRE-binding levels. An important implication of this observation is
that care should be taken when translating circulating GC levels into alleged changes in GC-sensitive
functions in the brain.
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Figure 3. Interaction of mineralocorticoid receptors (MRs) and glucocorticoid receptors (GRs) with
glucocorticoid responsive elements (GREs). Natural glucocorticoids (GCs; corticosterone in rodents;
cortisol in humans) bind to MRs and GRs, which are ligand-dependent transcription factors that can
bind to GREs within GC target genes, like Fkbp5, Per1 and Sgk1, and activate their transcription. MRs
and GRs exert these actions through the formation of homo- and/or heterodimers. Fkbp5: FK-506
binding protein; Per1: Period1; Sgk1: Serum/glucocorticoid-regulated kinase 1.
4. Early Life Stress, Epigenetic Dysregulation and Neuropsychiatric Disorders
Psychiatric disorders are heterogeneous and complex, arising from the interaction of many factors
such as neurobiology, genetics, cultural background, and life experience. Recent advances within
this field have demonstrated that epigenetic mechanisms play an important role in the development
and progression of these conditions, especially in early life. It has been well documented that adults
who experience childhood stress or trauma have a significantly higher risk of developing a range of
mood or other disorders [77,78]. Prenatal adverse environments such as maternal stress can disrupt
normal brain development and contribute to neurodevelopmental disorders such as schizophrenia and
depression [79,80]. The HPA axis is often found to be dysregulated in psychiatric disorders, particularly
in patients suffering from depression, post-traumatic stress disorder (PTSD), and anxiety disorders.
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4.1. Prenatal Exposure
There is substantial evidence demonstrating that a single acute traumatic experience of a parent
can have long-lasting effects on the offspring. This effect has been seen in offspring of mothers who
were pregnant and were near to or at the World Trade Centre when it was attacked in 2001 [81].
Previously, mothers and their offspring who both demonstrate reduced levels of cortisol [81] have been
linked to an enhanced vulnerability to PTSD [82]. The link, however, between reduced cortisol levels
and a predisposition to developing PTSD has been inconsistently reported [83]. The occurrence of
PTSD in parents who survived the Holocaust is also associated with lower urinary cortisol excretion in
the unexposed offspring (i.e., those conceived after the Holocaust) [82]. This study was later extended
by demonstrating that the lower urinary cortisol levels were associated with greater glucocorticoid
sensitivity in these offspring [84], which was only evident if the mother had PTSD as a result of living
through the Holocaust [85]. To avoid any direct in utero effects, the participants in the study consisted
only of offspring who were conceived after the parents had escaped from concentration camps or
after liberation. Nevertheless, any (pre-conception) effects on the oocytes of these traumatized women
cannot be excluded.
Parents that suffer from PTSD will often pass on an enhanced risk of developing PTSD to their
offspring; this is not to deliberately inflict trauma onto the offspring but rather it is thought to be
a physiological mechanism to prepare the offspring so that they are able to cope better with the
environment they will be subsequently born into. It should be noted that this is still a theoretical
concept. There are a number of hypotheses as to how information is passed on through the germ cells;
the main theory is the environment provided by the mother in utero. During prenatal development,
the epigenome is very susceptible to environmental exposures, and therefore this could be a potential
mechanism by which stress-inflicted effects are inherited through the germ cells. This theory has met
some scepticism since there is extensive epigenetic reprogramming taking place during embryogenesis
to establish cell and tissue-specific gene expression patterns. For instance, normally there is very little
variation between tissue-specific methylation patterns [86]; however, there are specific regions within
the genome that are more susceptible to variation and these are called metastable epialleles. It is in
these regions that establishment of methylation patterns during early development can vary, resulting
in variable gene expression and phenotype, but the question is: How do these epigenetic marks escape
the reprogramming?
Human studies have shown how early life events impact on the epigenome and persist into
adulthood. The Dutch Hunger Winter resulted in individuals being exposed to famine as a consequence
of the German occupation towards the end of the Second World War in the winter of 1944–1945.
An epigenetic epidemiological study demonstrated that prenatal exposure to famine is associated with
lower DNA methylation of the insulin-like growth factor 2 (IGF2) differentially methylated region
(DMR) which persisted over 6 decades [87]. Interestingly, this was only observed when exposure
occurred during early, but not late, gestation, indicating a critical period for DNA methylation changes
to occur. These babies were relatively small when they were born and, later in life, suffered from
diseases such as coronary heart disease and presented a two-fold increase in the risk of developing
schizophrenia [88].
4.2. Post-Natal Exposure
There is a substantial amount of evidence demonstrating that early-life events (post-natal) can
potentially have long-term consequences on behavior and stress responsivity that can persist into
adulthood. It has been shown that early life stress such as maternal separation in mice can induce
histone acetylation that correlates with the activation of synaptic plasticity genes Arc and Egr1 in the
hippocampus of the pups [89]. The authors speculated that this adaptation of the hippocampal synaptic
circuits occurs in order for the mice to cope with their stressful environment; however, direct evidence
is still lacking. The ability to vary phenotype in response to environmental conditions is referred to as
phenotypic plasticity. Early postnatal life is a period when the environment can influence emotional
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and cognitive development. Weaver et al. showed that rat mothers who were more nurturing towards
their offspring, as demonstrated by more pup licking (LG) and arched-back nursing (ABN), resulted in
a significantly reduced level of DNA methylation along the EGR1 binding site within the hippocampal
GR promoter in the pups [90]. The reduction in DNA methylation was associated with an increase
in hippocampal GR expression, enhanced glucocorticoid feedback sensitivity, and, as a consequence,
resulted in a stronger dampening of the HPA axis response to stress when compared with pups who
received low levels of LG and ABN. Accordingly, the offspring which received more maternal care
demonstrated decreased hypothalamic corticotropin-releasing factor (CRF) expression and a more
modest HPA response to stress. This was also reflected in the pup’s behavioral response to stress,
where they displayed less fearful behavior compared with those pups who had received a low level
LG and ABN [90]. This study further included a cross fostering experiment, in which they swapped
the pups from rat mothers who showed a high level of maternal care with those that displayed a
low level of maternal care. This resulted in the pups adopting a similar epigenetic and behavioral
profile to the foster mother rather than their biological mother demonstrating how the environment
can directly affect the epigenome and phenotype of the offspring. This phenotypic plasticity persisted
into adulthood with the foster pups also adopting the high level or low level maternal care of the
foster mother. It is interesting to consider that if the conditions experienced by the foetus in utero are
resulting in variations in the epigenome, could this be altered by early life postnatal experiences which
would persist into adulthood and if so, would they be permanent or can they be reversed?
Current evidence is lacking regarding the mechanism underpinning the persistence of epigenetic
marks into adulthood. Possibly, once the epigenetic marks are established, then, most likely, DNA
methylation is very stable in adulthood and so persists in mature post-mitotic neurons. There is
now, however, ample evidence that the epigenomic marks established early in life through behavioral
programming are reversible in the adult brain [91]. Moreover, there is growing evidence demonstrating
that epigenetic processes are highly dynamic in the mature post-mitotic neuron and, in fact, are essential
for neuronal plasticity [12,18,92].
The evidence that epigenetic mechanisms are involved in cognitive and adaptive responses
to stress is continuously growing and presently there are suggestions that the early life epigenetic
programming that appears to persist into adulthood may also be able to span generations. Therefore,
changes in the environment which can modify the epigenome could potentially be inherited.
4.3. Transgenerational Epigenetics
The idea that changes in the ancestral environment can be passed onto descendants is not
necessarily new. The developing foetus in utero could be directly affected if the mother were to
experience a harsh environment. Another example would be that parental behaviour early in life can
govern how the offspring behave as parents later in life. A new theory is now beginning to emerge
as to how environmental changes that alter the epigenetic profile of an individual can result in a
different phenotype (phenotypic plasticity) that can be inherited across generations. This non-genomic
inheritance through the generations is referred to as transgenerational epigenetics, but it has received
some scepticism too.
It is important at this stage to define intergenerational and transgenerational transmission.
Adult mice that are exposed to an adverse environment will be affected but so will the germ
cells; therefore, the subsequent F1 generation would be considered as intergenerational, and only
the F2 generation would be transgenerational. In pregnant females (F0 generation), however,
intergenerational inheritance will affect the developing fetus’s somatic and germ cells (F1 generation)
and the germ cells of the developing fetus (F2 generation); therefore, in order for transgenerational
inheritance to be considered, offspring should be studied in the F3 generation. The field of epigenetics
remains to be divided over the theory that epigenetics can transgress generations but there is
some fascinating research. Studies in mice provided compelling evidence of this phenomenon
and, interestingly, the majority of the work has focused on paternal transmission due to the fact
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that any transgenerational effects can be studied in the F2 generation. Work conducted by Dias
et al. using olfactory fear conditioning has suggested that parental traumatic exposure can be
inherited in a transgenerational epigenetic manner [93]. The experiment was based on olfactory
fear conditioning studies in which male mice (F0) were exposed to acetophenone (an odor that
activates the olfactory sensory neuron) and given a foot shock so that in subsequent exposures the mice
display fear behavior when presented with this specific odor. This F0 generation was mated with naive
female mice and the male F1 offspring was found to display enhanced sensitivity upon presentation
of acetophenone. Subsequently, an F2 generation was produced by in vitro fertilization (IVF) with
F0 sperm, along with cross fostering studies [93]. The authors suggested that the inheritance of the
enhanced sensitivity to acetophenone in subsequent generations was based on the sperm and that
this resulted in hypomethylation of the mouse odorant receptor gene M71 in F0 and F1 generations,
which may have led to enhanced gene transcription. The authors concluded the presence of both
intergenerational and transgenerational epigenetics. This conclusion raised the question as to how
environmental information can get into germ cells. This was explained by the odorants getting into the
circulatory system and potentially activating odorant receptors that are expressed in the sperm [93].
Explaining how specific loci can escape the epigenetic reprogramming which occurs after fertilization
and then again in the primordial germ cell remains unanswered. It has been shown, however, that some
loci associated with metabolic and neurological disorders can be resistant to DNA demethylation [94].
In a further study, chronically social defeated male mice were bred with naive female mice after
which their offspring (F1) was assessed for stress-related and anxiety-like behaviors [95]. The offspring
from the male mice who experienced chronic social defeat demonstrated an increase in anxiety-like
and stress-related behaviors compared with control mice, which was more apparent in the male
offspring; an observation that corresponds with those of Dias et al. [93] on olfaction fear conditioning.
Interestingly, these observations were not made when offspring was generated using IVF, indicating
that the behavioral effects observed were unlikely to be due to inheritance of epigenetic marks [95].
Consequently, there appears to be added complexity in that female mice may be altering their maternal
care of the offspring as a result of their exposure to a male mouse with a history of chronic stress [95].
While maternal influences on the stress response have been widely investigated, more studies
are now focusing on the potential role of paternal factors. Rodgers et al. [96] showed that chronic
paternal stress in both adolescent and adult mice resulted in a significantly reduced HPA axis
stress-responsivity [96]. These male mice were exposed to seven different stressors, which were
randomized and administered once per day over a 42-day period. The offspring of exposed mice
displayed reduced corticosterone responses to acute restraint. Gene set enrichment analyses on the
PVN and the bed nucleus of stria terminalis (BNST) demonstrated a global change in transcription
patterns which could be due to epigenetic reprogramming, resulting in increased expression of
glucocorticoid-responsive genes in the PVN, which is consistent with changes in offspring stress
responsivity [96]. The authors also showed that there was an increased expression of nine microRNAs
in sperm that were thought to underpin the altered stress responsivity in the offspring. The nine
microRNAs were shown to function post-fertilisation and were associated with a reduced HPA axis
response as assessed by measuring plasma corticosterone levels after restraint stress. The microRNAs
were injected into single cell zygotes, which only resulted in the same stress response phenotype when
all nine microRNAs were injected simultaneously. The sperm microRNAs are thought to selectively
target maternal mRNA resulting in post-transcriptional silencing of expression. The study did not,
however, explore each individual microRNA and their effects on stress responsivity. Nevertheless,
the study highlights the putative influence of transgenerational transmission of paternal experiences on
the health of the offspring and their resilience [97]. Male mice that had been exposed to unpredictable
maternal separation combined with unpredictable maternal stress (MSUS) showed disrupted metabolic
and behavioural phenotypes compared with control mice [98]. Deep sequencing analysis of small
non-coding RNAs, including microRNAs, present in sperm identified several microRNAs and piRNAs
(piwi-interacting RNAs) that were significantly affected by MSUS exposure. Interestingly, these effects
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(molecular, metabolic and behavioural) could also be induced in male offspring after microinjecting
RNAs purified from the sperm of MSUS exposed male mice to wildtype fertilised mouse oocytes. These
observations indicate that even in the absence of stress, small, non-coding RNA (sncRNAs) purified
from the sperm of stressed mice can transmit the MSUS phenotype to stress-naïve offspring [98].
In a more recent study, further evidence was found for transgenerational epigenetics. F1 male
offspring, which had been subjected to chronic and unpredictable maternal separation in early life,
were mated with wild-type females that produced an F2 generation. Male mice from the F2 generation
were then mated with wild-type females to produce the F3 generation. Increased floating or immobility
in the forced swim test and increased immobility in the tail suspension test were seen in the male
F1 generation but interestingly not in the females, with the reverse observed in the F2 generation
with males not displaying the same behavioral traits as the male F1 generation, while the females
did. The F3 generation was assessed and the males once again displayed increased floating in
the FS test and increased immobility in the tail suspension test. Furthermore, the unpredictable
maternal separation resulted in changes in DNA methylation across a number of candidate genes
(e.g., cannabinoid receptor-1 (CB1) and methyl CpG-binding protein 2 (MeCP2)). This research
indicates that stress-related behaviors may be transmitted across generations and in sex-specific
manner [99].
5. Epigenetics as Biomarkers and Therapeutic Treatments
Biomarkers ideally serve to give information about the presence or absence of disease and disease
characteristics. The mapping of the complete Human Genome Project (HGP) in April 2003 [100]
has assisted in the discovery of novel biomarkers and potential therapeutic targets for treatment
of disease. The HGP has also increased our capacity for gene therapy and in identifying single
nucleotide polymorphisms (SNPs) where a single nucleotide base in the DNA is mutated and can be
associated with a disease. The HGP has assisted with identifying genetic variants that may influence
the effectiveness or toxicity of a drug for an individual; this is referred to as pharmacogenomics [101].
Following on from the HGP the Epigenome Project is currently underway, aiming to characterize the
epigenome of healthy cell types, tissues, or individuals to obtain “reference” epigenomes. This project
is arguably much larger than the HGP due to the different epigenetic modifications and their potential
combinations that can dictate gene transcription in a tissue-specific manner. Having a complete
epigenome as a reference database, may speed up the production of epigenetic biomarkers and assist
in developing new therapeutic treatments. Whilst this is a compelling idea, generating a complete
epigenome for any cell, tissue, or animal is a monumental feat that may never be fully completed due to
the numerous combinations of epigenetic marks and their continual interaction with the ever-changing
environment. There is, consequently, now a rapidly evolving discipline called pharmacoepigenetics
that studies the effects of epigenetic factors on the individual variation in responses to drugs [102].
In an ideal world, personalized medicine would encompass different sources of information such as
the individual’s genetic and epigenetic make-up, RNA levels, proteins and various other metabolites
allowing for a more complete but more complex picture.
The pattern of aberrant DNA methylation changes in cancer is well established, with global
hypomethylation accompanied by targeted hypermethylation of some gene promoter CpG islands
(CGIs) and, in particular, tumor-suppressor genes [103]. This led to significant interest in finding DNA
methylation biomarkers for cancer classification and disease prognosis, with some success [104–106],
although it still remains a challenge to separate driver from passenger epigenetic changes.
There have also been advances in identifying aberrant patterns of histone modifications to provide
clinical information about cancer [107]. Additionally, studies have identified epigenetic changes
associated with other diseases such as lupus [108], diabetes [109], and asthma [110], with potential for
therapeutic intervention [111].
Epigenetic treatments are currently being used, with first generation epigenetic pharmaceuticals,
such as DNMT and HDAC inhibitors, currently FDA approved for cancer. Despite this, the lack
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of specificity for individual enzymes and toxicities means more work is needed to refine these
shortcomings and improve epigenetic drug discovery. The potential of epigenetic medicine to be
combined with conventional medicine to revolutionize the diagnosis and treatment of human diseases
is on the horizon.
6. Conclusions and Future Perspectives
The stress response, including the consolidation of memories of the stressful event, are essential
for an animal’s survival. The process of consolidating stress-related memories involves a number of
complex pathways such as the concomitant activation of NMDA-Rs and GRs resulting in the activation
of the ERK MAPK pathway, and subsequent epigenetic modifications and gene transcriptional
responses. GCs, therefore, play an integral part in producing long-lasting memories through this
recently discovered non-genomic mechanism [4,13,27]. Classically, however, GC action through
MRs and GRs occurs through genomic mechanisms. Although these mechanisms have been known
since the 1980s, it is still unknown which MR- and/or GR-regulated genes are critically involved in
stress-related memory formation. Due to advancements in the ChIP technology, the state of knowledge
is presently rapidly progressing. Recently, we reported for the first time on the binding of MRs
and GRs to GC target genes in the hippocampus after stress in vivo [10] The combination of ChIP
with next-generation sequencing will soon lead to the elucidation of the MR- and GR-targeted genes
involved in stress-associated learning and memory responses. Furthermore, adding to the complexity
of GC action in the brain, our research has shown that the expression of GR is diminished after a
stressful challenge, possibly as a result of enhanced DNA methylation and microRNA action.
The long-term impact of epigenetic changes is underscored by the often life-long effects of
manipulations inflicted upon the unborn organism in utero or on the newborn during early life.
Evidence has been accumulating indicating that epigenetic marks could be transgenerationally
transmitted through the germ line. Further research is needed to understand the molecular and
epigenetic mechanisms underpinning this process.
The influence of the environment on epigenetic mechanisms is now recognized and is being
targeted as a source of potential biomarkers in the diagnosis of various diseases but as a potential
target for therapeutic treatment as well. These endeavors are, however, a long way off but may be
assisted by advancements in the Human Epigenome Project. This project is of course very ambitious
and will be infinitely more complex when compared with the Human Genome Project. With the
idea of tailoring medicine for individuals based on their specific epigenetic (and genomic) profile
with pharmaco-epigenetics facilitated by advancing technologies, personalized medicine may become
a reality.
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